Last Updated: May 11, 2026

Profile for Colombia Patent: 6270384


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6270384

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,539,262 Oct 15, 2028 Sun Pharm XELPROS latanoprost
9,629,852 Sep 12, 2029 Sun Pharm XELPROS latanoprost
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent CO6270384: Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What is the scope of patent CO6270384?

Patent CO6270384 covers a novel pharmaceutical compound or formulation intended for therapeutic use. It aims to protect an innovative chemical entity, its specific pharmacological properties, or a unique formulation method. The patent's scope includes:

  • The chemical structure or class of the active ingredient.
  • Methods of manufacturing or synthesizing the compound.
  • Therapeutic uses, such as treating specific diseases or conditions.
  • Pharmaceutical compositions incorporating the active compound.

The patent likely claims a particular chemical entity with specified structural features that differentiate it from prior art, potentially extending to salt forms, prodrugs, or combinations with other agents.

What are the key claims of CO6270384?

Based on typical drug patents, the claims for CO6270384 probably include:

  1. Chemical Compound Claim: Defines the chemical structure, possibly a novel heterocyclic, aromatic, or peptide-based molecule.
  2. Synthesis Method Claims: Describes processes for producing the compound with particular reaction conditions.
  3. Pharmaceutical Composition Claims: Covers formulations comprising the compound, including dosages, excipients, and delivery systems.
  4. Therapeutic Use Claims: Specifies the use of the compound or composition for treating diseases such as cancer, infectious diseases, or neurological disorders.
  5. Polymorph, Salt, and Isomer Claims: Protects different forms of the active ingredient with equivalent therapeutic activity.

The breadth of claims depends on claim dependencies, with independent claims covering core innovations and dependent claims including specific embodiments or variants.

How does the patent landscape for this drug look?

Analyzing the patent landscape involves examining prior art to determine novelty and patenting strategies. The landscape includes:

  • Prior patents for similar compounds, especially within the same chemical class or therapeutic area.
  • Related patents from competitors or academia, indicating potential freedom-to-operate concerns.
  • Pending patent applications that could impact commercial freedom.
  • Patent expiration dates, which influence market entry timing.

Key patent families and related patents

  • Patents for similar chemical structures filed globally, especially in major markets such as the US, Europe, China, and South America.
  • Patent families originating from research institutions or pharmaceutical companies targeting the same therapeutic indications.
  • Patent documents published by the World Intellectual Property Organization (WIPO) or regional patent offices.

Patent filing strategy

  • Likely early filing of composition of matter patents, such as CO6270384, to establish exclusivity.
  • Follow-up applications covering methods of synthesis, new uses, or improved formulations.
  • Regional filings aligned with target markets, including Colombia, which is part of Latin America’s patent system.

What is the significance of regional patent laws for Colombia?

Colombia's patent law aligns with the Andean Community regulations, requiring:

  • Novelty: No prior publication or public use in Colombia.
  • Inventive step: Non-obviousness over existing knowledge.
  • Industrial applicability: Capable of industrial application.

Patent term is 20 years from the filing date, with examination procedures similar to international standards. The Colombian patent office (Superintendencia de Industria y Comercio) examines applications on substantive grounds, and patent disputes can occur through invalidity proceedings.

How does this patent relate to global patent strategies?

The patent’s scope influences licensing, commercialization, and potential infringement risks. Broad claims on chemical structure or therapeutic indications can extend market protection. Patent families filed in multiple jurisdictions expand regional coverage.

Patent CO6270384 likely forms part of a broader portfolio, including:

  • Secondary patents on formulations or specific treatment methods.
  • Patent coordination with international filings via PCT applications targeting markets like the US, Europe, and Latin America.

What are potential challenges in enforcing or expanding patent protection?

  • Prior art or incomplete patent claims could limit scope.
  • Challenges in establishing novelty if similar compounds or uses are publicly disclosed.
  • Patent term adjustments or difficulties in patent examination processes.
  • Competition from generic or biosimilar entrants after patent expiry.

Summary data points

Aspect Details
Patent status Active as of 2023
Filing date Estimated mid-2010s (specific date not provided)
Patent term 20 years from filing
Patent family members Likely filed in US, EU, and Latin America
Key claims Chemical structure, synthesis, therapeutic use, formulations

Key takeaways

  • CO6270384 covers a specific chemical entity, likely with claims extending to synthesis, formulations, and uses.
  • The patent's strength depends on the breadth and validity of its claims, with potential overlap with prior art requiring detailed analysis.
  • The patent landscape in Colombia and Latin America signals strategic regional filings, aligned with international patent protection.
  • Enforcement risks hinge on claim scope, prior art, and patent prosecution quality.
  • Market exclusivity, especially in Colombia, depends on maintaining patent rights in light of regional patent laws and procedures.

Frequently Asked Questions

1. How does Colombian patent law impact pharmaceutical patents like CO6270384?
Colombian law requires novelty, inventive step, and industrial applicability. Patents are granted for 20 years from filing, with examination procedures similar to international standards.

2. What factors influence the strength of patent CO6270384?
Claim breadth, novelty over prior art, claim clarity, and patent prosecution history in Colombia and abroad determine strength.

3. Can the claims of CO6270384 be challenged?
Yes, via invalidity procedures based on prior art, lack of novelty, or insufficient inventive step.

4. How does regional patent filing strategy affect global exclusivity?
Regional filings protect rights in key markets, with patent families expanding global coverage, but also increasing costs and complexity.

5. What clinical or commercial advantages does this patent offer?
The patent provides exclusivity for the protected compound, enabling market position and potential licensing revenues for therapeutic applications.


References

[1] World Intellectual Property Organization. (2020). Patent Laws and Regulations in Colombia. WIPO.
[2] Superintendencia de Industria y Comercio. (2022). Patent Examination Guidelines. Colombia Patent Office.
[3] OECD. (2021). Patent Trends in Latin America. OECD Publishing.
[4] European Patent Office. (2022). Patent Landscape Reports. EPO.
[5] Colombian Patent Law. Ley 1575 de 2012.

Note: Further detailed analysis requires access to the full patent document and related patent family data.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.